Valion Bio (VBIO) Current Assets (2021 - 2026)
Valion Bio (VBIO) posted quarterly Current Assets of $13.0 million for Q4 2025, up 392.84% year-over-year from $2.6 million in Q4 2024, and up 247.75% quarter-over-quarter from $3.7 million in Q3 2025.
Valion Bio (VBIO) Current Assets (2021 - 2026) Analysis & Trends
Valion Bio's Current Assets history runs 5 years deep, the most recent figure standing at $13.0 million for Q4 2025.
- In Q4 2025, Current Assets rose 392.84% year-over-year to $13.0 million; the TTM figure through Dec 2025 stood at $13.0 million (up 392.84% YoY), while the FY2025 annual figure was $13.0 million, up 392.84% from the prior year.
- Current Assets for Q4 2025 stood at $13.0 million, up from $3.7 million in the prior quarter.
- The five-year high for Current Assets was $14.3 million in Q4 2021, with the low at $1.3 million in Q1 2025.
- The 5-year median for Current Assets is $4.7 million (2024), against an average of $6.1 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets sank 62.87% in 2022, then jumped 392.84% in 2025.
- Valion Bio's Current Assets stood at $14.3 million in 2021, then tumbled by 62.87% to $5.3 million in 2022, then retreated by 12.33% to $4.7 million in 2023, then slumped by 43.27% to $2.6 million in 2024, then jumped by 392.84% to $13.0 million in 2025.
- Business Quant data shows VBIO's Current Assets at $13.0 million in Q4 2025, $3.7 million in Q3 2025, and $1.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Dec 31, 2025 | 13.01 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 4.65 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | 6.48 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 7.59 Mn |
| Jun 30, 2022 | 10.37 Mn |
| Mar 31, 2022 | 12.00 Mn |
| Dec 31, 2021 | 14.29 Mn |